The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.

Moderna says it has become the first company in the pharma sector with phase 3 data on a combined vaccine for both COVID-19 and influenza and will soon be ready to discuss “next steps” with ...

Yatra Nari Astu Pujyante Ramante Tatra Devataa The Gods reside in places where woman is worshiped Manu SmritiWomen had a very significant position in our ancient Indian society In fact they were super ...

The Exchange has sought clarification from Hindustan Petroleum Corporation Ltd with reference to the media report appearing on https://www.cnbctv18.com March 10, 2025 ...